Anaplastic Large Cell Lymphoma: Update of Findings
- 1 January 1995
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 18 (1) , 17-25
- https://doi.org/10.3109/10428199509064918
Abstract
The problem of anaplastic large cell lymphoma (ALCL) is extensively reviewed by depicting the clinical, pathological and biological characteristics of the four main varieties of ALCL: common, Hodgkin's like/Hodgkin-related, lympho-histiocytic, and giant-cell rich. Special emphasis is given to the differential diagnosis between ALCL Hodgkin like and Hodgkin's disease in the light of possible therapeutical differences.Keywords
This publication has 46 references indexed in Scilit:
- CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNFCell, 1993
- Assignment of the human CD30 (Ki-1) gene to 1p36Genomics, 1992
- Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's diseaseCell, 1992
- CD30 expression in non‐Hodgkin's lymphomaHistopathology, 1990
- The diagnostic significance of the CD30 (Ki‐1) antigenHistopathology, 1990
- CD30(Ki-1) Antigen Expression in a Subset of Gastric Mucosal Plasma Cells and in a Primary Gastric PlasmacytomaAmerican Journal of Clinical Pathology, 1989
- Ki-1 Positive Large Cell LymphomaThe American Journal of Surgical Pathology, 1988
- Ki-1 lymphomas in childrenCancer, 1988
- UPDATED KIEL CLASSIFICATION FOR LYMPHOMASThe Lancet, 1988
- Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cellsNature, 1982